Lapisteride

DB21206ExperimentalSmall molecule

Lapisteride is a small molecule drug. The usage of the INN stem '-steride' in the name indicates that Lapisteride is a androgen/anabolic steroid. Lapisteride has a monoisotopic molecular weight of...

Mechanism: Pharmacologically active on 3-oxo-5-alpha-steroid 4-dehydrogenase
Curator reviewed
Formula / weight: C₂₉H₄₀N₂O₃ · 464.65 g/mol (avg)

Resolves to

Compound

UNIIT50SJ23G82CAS142139-60-4ChEMBLCHEMBL2104358

Structure

InChIKeyNAGKTIAFDQEFJI-DPMIIFTQSA-NSMILES[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])NC(=O)C=C[C@]4(C)[C@@]3([H])CC[C@]12C)C(=O)NC(C)(C)C1=CC=C(OC)C=C1

What you can answer from here — as of September 16, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

4+ReferencesStructured and connected to the statements they support

Which companies are running trials of Lapisteride, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account